Close Menu

NEW YORK – German diagnostics company InfanDx announced on Tuesday it has been awarded a grant for more than €1 million ($1.1 million) to jointly develop a companion diagnostic test to determine whether newborns may benefit from neuroprotective hypothermia treatment.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.